Medline’s Huge IPO Is a Bet on a Quieter Healthcare Giant
Medline, a massive but low-profile medical supply company, priced its IPO at $29 per share, raising $6.26 billion. The deal marks the largest U.S. listing since Rivian in 2021 and gives the company a market value of at least $37 billion.